ArticleAdvances in therapy2018

Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).

Tetsuro Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.